HealthTree Foundation for Juvenile Myelomonocytic Leukemia, Bispecific Antibodies (BsAb) Treatments and Medications
[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account
arrow_back TREATMENTS
Bispecific Antibodies (BsAb)
Bispecific antibodies act as a go-between, recognizing and attaching to cancer cells and joining them to the immune system’s T cells. That cancer cell-to-T cell attachment results in the T cells attacking cancer cells.
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Juvenile Myelomonocytic Leukemia Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.